Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-43,759
Closed -$2.16M 1034
2022
Q2
$2.16M Sell
43,759
-156,681
-78% -$7.77M 0.01% 757
2022
Q1
$10.6M Buy
200,440
+11,643
+6% +$651K 0.05% 419
2021
Q4
$12.9M Buy
188,797
+95,730
+103% +$6.73M 0.05% 334
2021
Q3
$7.04M Buy
93,067
+23,695
+34% +$2.03M 0.03% 477
2021
Q2
$6.94M Buy
69,372
+31,423
+83% +$2.92M 0.03% 494
2021
Q1
$3.36M Sell
37,949
-7,373
-16% -$729K 0.02% 618
2020
Q4
$4.35M Hold
45,322
0.02% 529
2020
Q3
$2.75M Buy
45,322
+18,603
+70% +$1.18M 0.02% 573
2020
Q2
$1.77M Buy
+26,719
New +$1.7M 0.01% 787

Other funds holding ITRI

Aviva's ITRI Position: Q3 2022 in Review

Aviva sold out of Itron (ITRI) in Q3 2022, closing a stake of 43,759 shares — an estimated $2.16M sold.

Aviva first reported a position in ITRI in Q2 2020 and held it in 9 quarters. The position peaked at $12.9M in Q4 2021. 241 funds tracked by Wall St. Rank hold ITRI as of Q3 2022.

  • Aviva reported no remaining Itron position as of Q3 2022 after selling out during the quarter.
  • Aviva sold 43,759 Itron shares in Q3 2022, an estimated $2.16M.
  • Aviva first reported a position in Itron in Q2 2020 and held it in 9 quarters.
  • Aviva's Itron position peaked at $12.9M in Q4 2021.
  • 241 funds tracked by Wall St. Rank held Itron as of Q3 2022.

Based on Aviva's 13F filing for Q3 2022, filed 14 Nov 2022.